Study Details Effectiveness of mNGS for Infectious Disease Diagnosis
Delve Bio announced data on the use of mNGS for the definitive diagnosis of infectious causes of meningitis and/or encephalitis.
Read MorePosted by Andy Lundin | Apr 17, 2024 | Infectious Diseases |
Delve Bio announced data on the use of mNGS for the definitive diagnosis of infectious causes of meningitis and/or encephalitis.
Read MorePosted by Andy Lundin | Apr 12, 2024 | Emerging & Zoonotic Diseases |
The FDA granted EUA for Labcorp’s Mpox PCR Test Home Collection Kit, facilitating the early detection and management of mpox infections.
Read MorePosted by Andy Lundin | Apr 11, 2024 | Urinalysis & Toxicology |
QuidelOrtho added the immunoassay for the qualitative detection of fentanyl to its Vitros systems to address the need for opioid testing.
Read MorePosted by Andy Lundin | Apr 5, 2024 | Cardiovascular |
Analytics for Life and CorVista Health announced U.S. FDA clearance of the CorVista System with Pulmonary Hypertension (PH) Add-On Module
Read MorePosted by Andy Lundin | Mar 28, 2024 | Molecular Diagnostics |
A single genetic test could potentially replace the current two-step approach to diagnosing rare developmental disorders in children.
Read More